Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Alzheimer's Disease

Free Subscription 11.05.2025 1 Acta Neuropathol 7 Alzheimers Dement 1 Am J Alzheimers Dis Other Demen 1 Am J Geriatr Psychiatry 1 Ann Pharmacother 1 Brain 1 Brain Res 1 Curr Alzheimer Res 1 Dement Geriatr Cogn Disord 1 Exp Gerontol 17 J Alzheimers Dis 1 J Am Geriatr Soc 1 J Neuropsychol 1 Neuro Endocrinol Lett 4 Neurobiol Aging 1 Neurochem Res 1 Neuroscience 7 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. KAVANAGH T, Thierry M, Balcomb K, Ponce J, et al
   The interactome of tau phosphorylated at T217 in Alzheimer's disease human brain tissue.
   Acta Neuropathol. 2025;149:44.
   PubMed         Abstract available
   
   

   
   Alzheimers Dement

2. REA REYES RE, Wilson RE, Langhough RE, Studer RL, et al
   Targeted proteomic biomarker profiling using NULISA in a cohort enriched with risk for Alzheimer's disease and related dementias.
   Alzheimers Dement. 2025;21:e70166.
   PubMed         Abstract available
   
   
3. CHICOTE-GONZALEZ A, Solana-Balaguer J, Garcia-Segura P, Campoy-Campos G, et al
   Astrocytes, via RTP801, contribute to cognitive decline by disrupting GABAergic-regulated connectivity and driving neuroinflammation in an Alzheimer's disease mouse model.
   Alzheimers Dement. 2025;21:e70051.
   PubMed         Abstract available
   
   
4. CHEN XQ, Zuo X, Becker A, Mobley WC, et al
   Hyperactivation of RAB5 disrupts the endosomal Rab cascade leading to endolysosomal dysregulation in Down syndrome: A necessary role for increased APP gene dose.
   Alzheimers Dement. 2025;21:e70046.
   PubMed         Abstract available
   
   
5. CHEN XQ, Zuo X, Becker A, Mante M, et al
   Antisense oligonucleotides directed against App and Rab5 normalized endosomal Rab activity and reversed DS-AD-linked degenerative phenotypes in the Dp16 mouse model of Down syndrome.
   Alzheimers Dement. 2025;21:e70022.
   PubMed         Abstract available
   
   
6. MANESCU MD, Catalin B, Baldea I, Mateescu VO, et al
   Aquaporin 4 modulation drives amyloid burden and cognitive abilities in an APPPS1 mouse model of Alzheimer's disease.
   Alzheimers Dement. 2025;21:e70164.
   PubMed         Abstract available
   
   
7. PTOMEY LT, Donnelly JE, Burns J, Morris J, et al
   Brain outcomes with lifestyle change in adults with Down syndrome: Rationale and design for a 12-month randomized trial.
   Alzheimers Dement. 2025;21:e70219.
   PubMed         Abstract available
   
   
8. WEI M, Zhang Y, Wang M, Zhong J, et al
   Plasma biomarkers as core mediators in functional network abnormalities: Evidence from a two-cohort study.
   Alzheimers Dement. 2025;21:e70114.
   PubMed         Abstract available
   
   

   
   Am J Alzheimers Dis Other Demen

9. LUO Z, Wang SP, Ho EH, Yao L, et al
   Predicting and Evaluating Cognitive Status in Aging Populations Using Decision Tree Models.
   Am J Alzheimers Dis Other Demen. 2025;40:15333175251339730.
   PubMed         Abstract available
   
   

   
   Am J Geriatr Psychiatry

10. YANG Y, Kwak YT
    Network Analysis of Delusion Subtypes in Amyloid PET-Positive, Drug-Naive Alzheimer's Disease Patients.
    Am J Geriatr Psychiatry. 2025 Apr 22:S1064-7481(25)00329.
    PubMed         Abstract available
    
    

    
    Ann Pharmacother

11. ISOTALO HK, Lehtovaara JK, Ekblad LL, Nuotio MS, et al
    Effects of Cholinesterase Inhibitor Medication on QTc Interval in Memory Clinic Patients.
    Ann Pharmacother. 2025 May 6:10600280251328530. doi: 10.1177/10600280251328530.
    PubMed         Abstract available
    
    

    
    Brain

12. RICKENBACH C, Mallone A, Hausle L, Frei L, et al
    Altered T-cell reactivity in the early stages of Alzheimer's disease.
    Brain. 2025 May 5:awaf167. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Brain Res

13. MA XH, Dai H, Liu SY, Liu XN, et al
    Protection of dauricine and daurisoline on PC12 cells damaged by glutamate or Abeta(25-35).
    Brain Res. 2025;1857:149609.
    PubMed         Abstract available
    
    

    
    Curr Alzheimer Res

14. SI Y, Meng B, Qi F
    Age- and Genotype-Dependent Effects of Chronic Nicotine on Presenilin1/2 Double Knockout Mice: From Behavior to Molecular Pathways.
    Curr Alzheimer Res. 2024;21:817-832.
    PubMed         Abstract available
    
    

    
    Dement Geriatr Cogn Disord

15. ZHANG ZZ, Lyu XY, Dai XW, Cong JN, et al
    Validity and Reliability of Outcome Measurement Instruments for Cognitive Function in Alzheimer's Disease: A Systematic Review.
    Dement Geriatr Cogn Disord. 2025 May 3:1-30. doi: 10.1159/000545907.
    PubMed         Abstract available
    
    

    
    Exp Gerontol

16. LIAO R, Yang J, Huang X, Xu Y, et al
    Dietary inflammatory index and Alzheimer's disease mortality in a prospective cohort.
    Exp Gerontol. 2025;206:112770.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

17. HOILUND-CARLSEN PF, Werner TJ, Alavi A
    The unsafe profile of lecanemab.
    J Alzheimers Dis. 2025;105:62-64.
    PubMed         Abstract available
    
    
18. LOBUE C, Stopschinski BE, Calveras NS, Salter A, et al
    A preliminary study on plasma markers across cognitive stages and links to a history of mild traumatic brain injury.
    J Alzheimers Dis. 2025;105:49-55.
    PubMed         Abstract available
    
    
19. YANG YH, Chang HW, Chien CF, Hour TC, et al
    Investigating the effects of 40 Hz sound stimulation on Alzheimer's disease pathways: Modulation of amyloid-beta42 secretion, tau phosphorylation, phagocytosis, and autophagy.
    J Alzheimers Dis. 2025 May 4:13872877251339774. doi: 10.1177/13872877251339774.
    PubMed         Abstract available
    
    
20. VOGELS L, Mohammadi R, Schoonhoven M, Birbil SI, et al
    Modeling Alzheimer's disease: Bayesian copula graphical model from demographic, cognitive, and neuroimaging data.
    J Alzheimers Dis. 2025 May 4:13872877251337944. doi: 10.1177/13872877251337944.
    PubMed         Abstract available
    
    
21. MO D, Li X, He J, Lin X, et al
    Chronic gingivitis increases the risk of early-onset Alzheimer's disease.
    J Alzheimers Dis. 2025 May 4:13872877251336259. doi: 10.1177/13872877251336259.
    PubMed         Abstract available
    
    
22. LI MJ, Lan MN, Du YX, Liu Y, et al
    EPRCN exerts neuroprotective function by regulating gut microbiota and restoring gut immune homeostasis in Alzheimer's disease model mice.
    J Alzheimers Dis. 2025 May 5:13872877251339762. doi: 10.1177/13872877251339762.
    PubMed         Abstract available
    
    
23. ITO K, Washimi Y, Kato T, Suzuki K, et al
    (18)F-FDG PET for the differential diagnosis of Alzheimer's disease and frontotemporal lobar degeneration: A multicenter prospective study in Japan.
    J Alzheimers Dis. 2025 May 5:13872877251338691. doi: 10.1177/13872877251338691.
    PubMed         Abstract available
    
    
24. NAGATA T, Nakajima S, Kito S, Shinagawa S, et al
    Correlations between agitation and other neuropsychiatric symptoms in each stage of Alzheimer's disease: A re-analysis of CATIE-AD.
    J Alzheimers Dis. 2025 May 5:13872877251340402. doi: 10.1177/13872877251340402.
    PubMed         Abstract available
    
    
25. SANDBERG A, Puttagunta S, Duval N, Fleming H, et al
    Immunocal((R)), a cysteine-rich whey protein, rescues reelin and reduces amyloid plaque burden in a transgenic amyloid-beta protein precursor (hAbetaPP(SweInd)) mouse model of Alzheimer's disease.
    J Alzheimers Dis. 2025 May 5:13872877251338323. doi: 10.1177/13872877251338323.
    PubMed         Abstract available
    
    
26. WU R, Guo J, Liu Y, Huang S, et al
    Angiogenesis promotion of the transplantation of human amniotic mesenchymal stem cells via the Ang-1/Tie-2 signaling pathways in Alzheimer's disease model.
    J Alzheimers Dis. 2025 May 5:13872877251338687. doi: 10.1177/13872877251338687.
    PubMed         Abstract available
    
    
27. KORIATH CA, Perneczky R
    Obesity and Alzheimer's disease dementia: Examining inflammatory links to cognitive decline and neuropsychiatric symptoms.
    J Alzheimers Dis. 2025 May 6:13872877251338467. doi: 10.1177/13872877251338467.
    PubMed         Abstract available
    
    
28. WANG T, Jiang H, Zheng R, Zhang C, et al
    Trends and research focus on autophagy in Alzheimer's disease (2003-2023): A bibliometric study.
    J Alzheimers Dis. 2025 May 6:13872877251336442. doi: 10.1177/13872877251336442.
    PubMed         Abstract available
    
    
29. VON GAL A, Papa D, D'Auria M, Piccardi L, et al
    Disruptive resting state networks characterizing depressive comorbidity in Alzheimer's disease and mild cognitive impairment.
    J Alzheimers Dis. 2025 May 6:13872877251337770. doi: 10.1177/13872877251337770.
    PubMed         Abstract available
    
    
30. ZHANG J, Liu T, Wu H, Wei J, et al
    Identification of NDUFV2, NDUFS7, OPA1, and NDUFA1 as biomarkers for Alzheimer's disease: Insights from oxidative stress and mitochondrial dysfunction in the hippocampus.
    J Alzheimers Dis. 2025 May 7:13872877251339771. doi: 10.1177/13872877251339771.
    PubMed         Abstract available
    
    
31. NYONGESA CA, Hogarth M, Pa J
    Artificial intelligence-driven natural language processing for identifying linguistic patterns in Alzheimer's disease and mild cognitive impairment: A study of lexical, syntactic, and cohesive features of speech through picture description tasks.
    J Alzheimers Dis. 2025 May 7:13872877251339756. doi: 10.1177/13872877251339756.
    PubMed         Abstract available
    
    
32. QIN Q, Xia X, Qu J, Guan Z, et al
    Blood biomarkers of amyloid and tau pathologies, brain degeneration, inflammation, and oxidative stress in early- and late-onset Alzheimer's disease.
    J Alzheimers Dis. 2025 May 8:13872877251340955. doi: 10.1177/13872877251340955.
    PubMed         Abstract available
    
    
33. CUMBO E, Migliore D
    Differential effects of antidepressants on cognition in Alzheimer's disease with depression: A sub-group analysis of an open-label, observational study.
    J Alzheimers Dis. 2025 May 7:13872877251340084. doi: 10.1177/13872877251340084.
    PubMed         Abstract available
    
    

    
    J Am Geriatr Soc

34. PISCITELLO G, Lingler J, Ramos K, Schenker Y, et al
    Assessing the Content of Goals of Care Documentation for Hospitalized Patients With Alzheimer's Disease and Related Dementias.
    J Am Geriatr Soc. 2025 May 2. doi: 10.1111/jgs.19502.
    PubMed         Abstract available
    
    

    
    J Neuropsychol

35. GRASSO SM, Santos-Santos MA, Clark AL
    On the complexity of biomarker-driven diagnoses of Alzheimer's disease.
    J Neuropsychol. 2025 May 2. doi: 10.1111/jnp.12428.
    PubMed         Abstract available
    
    

    
    Neuro Endocrinol Lett

36. STRAKA M, Supler M, Straka M
    Tooth loss, periodontal infection and their relationship to cognitive impairment and other dementias: A review.
    Neuro Endocrinol Lett. 2024;45.
    PubMed         Abstract available
    
    

    
    Neurobiol Aging

37. LUO T, Vattathil SM, Lori A, Schneider JA, et al
    Brain microRNAs differentially expressed in age-related cerebral pathologies.
    Neurobiol Aging. 2025;151:42-53.
    PubMed         Abstract available
    
    
38. PELEGRINI LNC, Manzine PR, Popolin CP, Dorta S, et al
    Higher soluble ADAM10 plasma levels are associated with decreased cognitive performance in older adults carrying APOEepsilon4.
    Neurobiol Aging. 2025;151:70-75.
    PubMed         Abstract available
    
    
39. NAJDEK C, Walle P, Flaig A, Ayral AM, et al
    Calpain and caspase regulate Abeta peptide production via cleavage of KINDLIN2 encoded by the AD-associated gene FERMT2.
    Neurobiol Aging. 2025;151:117-125.
    PubMed         Abstract available
    
    
40. MCKEAN NE, Liu J, Rudiger SR, Kelly JM, et al
    Presenilin 1 hemizygosity has no overt deleterious phenotypic outcomes in sheep: Potential implications for therapeutic targets in Alzheimer's disease.
    Neurobiol Aging. 2025;152:25-33.
    PubMed         Abstract available
    
    

    
    Neurochem Res

41. HU Y, Liu Y, Zhu Q, Chen Y, et al
    Identification of Novel Biomarkers Related to Vesicle Trafficking in Alzheimer's Disease Using Bioinformatics Approaches.
    Neurochem Res. 2025;50:157.
    PubMed         Abstract available
    
    

    
    Neuroscience

42. YANG Q, Huang D, Zhang Z, Gao H, et al
    Diabetes affects AD through plasma Abeta40: A Mendelian randomization study.
    Neuroscience. 2025;575:131-139.
    PubMed         Abstract available
    
    

    
    PLoS One

43. TAO F, Deng S, Zhuo B, Liu J, et al
    Causal relationship between schizophrenia and five types of dementia: A bidirectional two-sample Mendelian randomization study.
    PLoS One. 2025;20:e0322752.
    PubMed         Abstract available
    
    
44. 
    Retraction: Structure-based virtual screening of Trachyspermum ammi metabolites targeting acetylcholinesterase for Alzheimer's disease treatment.
    PLoS One. 2025;20:e0324094.
    PubMed        
    
    
45. LIU S, Geng D
    A systematic analysis for disease burden, risk factors, and trend projection of Alzheimer's disease and other dementias in China and globally.
    PLoS One. 2025;20:e0322574.
    PubMed         Abstract available
    
    
46. CATTO F, Kirschenbaum D, Economides AE, Reuss AM, et al
    Quantitative 3D histochemistry reveals region-specific amyloid-beta reduction by the antidiabetic drug netoglitazone.
    PLoS One. 2025;20:e0309489.
    PubMed         Abstract available
    
    
47. BRUNO F, Aceto MA, Paparazzo E, Arcuri D, et al
    Genetic variability in ADAM17/TACE is associated with sporadic Alzheimer's disease risk, neuropsychiatric symptoms and cognitive performance on the Rey Auditory Verbal Learning and Clock Drawing Tests.
    PLoS One. 2025;20:e0309631.
    PubMed         Abstract available
    
    
48. SADEGHI A, Noorbakhshnia M, Khodashenas S
    Protective potential of BM-MSC extracted Exosomes in a rat model of Alzheimer's disease.
    PLoS One. 2025;20:e0320883.
    PubMed         Abstract available
    
    
49. KAYHAN KOCAK FO, Kumral E
    The relationship between dementia staging scales, cognitive-behavioral scales and functionality in patients with cognitive impairment.
    PLoS One. 2025;20:e0322572.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.